-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Context Therapeutics Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q3 2020 to Q3 2025.
- Context Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 95,185,187, a 18% increase year-over-year.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 58,416,141, a 266% increase from 2023.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 15,966,053, unchanged from 2022.
- Context Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15,966,053, a 463% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)